ArticleACS omega2026
Cytotoxicity and Cellular Mechanisms of Novel Polymeric 2,4D Nanopesticide on Human Lung Epithelial A549 Cells.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanotechnology offers promising ecosustainable solutions for crop protection, but the use of nanopesticides, such as 2,4-dichlorophenoxyacetic acid-loaded polymeric nanopesticides (2,4D-NPs), presents significant human health risks, particularly via inhalation. This study was carried out to assess the cytotoxicity and underlying mechanisms of 2,4D-NPs on human lung epithelial A549 cells, which were selected as a representative model for the primary site of inhalation exposure. The synthesized 2,4D-NPs were well-defined spherical particles with an average size of approximately 49 nm, a negative ζ potential, and high encapsulation efficiency, confirming successful nanoformulation. Cytotoxicity assessments showed that the 2,4D-NPs had a significantly enhanced effect compared to raw 2,4D, with an IC
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.